BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32353377)

  • 1. Tight junction modulation at the blood-brain barrier: Current and future perspectives.
    Hashimoto Y; Campbell M
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183298. PubMed ID: 32353377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
    Greene C; Campbell M
    Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice.
    Li CH; Shyu MK; Jhan C; Cheng YW; Tsai CH; Liu CW; Lee CC; Chen RM; Kang JJ
    Toxicol Sci; 2015 Nov; 148(1):192-203. PubMed ID: 26272951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway.
    Xue Y; He JT; Zhang KK; Chen LJ; Wang Q; Xie XL
    Biochem Biophys Res Commun; 2019 Feb; 509(2):395-401. PubMed ID: 30594393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight junction modulators for drug delivery to the central nervous system.
    Hashimoto Y; Tachibana K; Kondoh M
    Drug Discov Today; 2020 Aug; 25(8):1477-1486. PubMed ID: 32439607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
    Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
    Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery.
    Dithmer S; Staat C; Müller C; Ku MC; Pohlmann A; Niendorf T; Gehne N; Fallier-Becker P; Kittel Á; Walter FR; Veszelka S; Deli MA; Blasig R; Haseloff RF; Blasig IE; Winkler L
    Ann N Y Acad Sci; 2017 Jun; 1397(1):169-184. PubMed ID: 28505395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.
    Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA
    J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.
    Deli MA
    Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
    Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
    J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood-Brain Barrier.
    Hashimoto Y; Campbell M; Tachibana K; Okada Y; Kondoh M
    Biol Pharm Bull; 2021; 44(10):1380-1390. PubMed ID: 34602546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model.
    Yan L; Dwiggins CW; Moriarty RA; Jung JW; Gupta U; Brandon KD; Stroka KM
    Acta Biomater; 2023 Sep; 167():109-120. PubMed ID: 37302732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells.
    Hülper P; Veszelka S; Walter FR; Wolburg H; Fallier-Becker P; Piontek J; Blasig IE; Lakomek M; Kugler W; Deli MA
    Br J Pharmacol; 2013 Aug; 169(7):1561-73. PubMed ID: 23617601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.
    Xu L; Dan M; Shao A; Cheng X; Zhang C; Yokel RA; Takemura T; Hanagata N; Niwa M; Watanabe D
    Int J Nanomedicine; 2015; 10():6105-18. PubMed ID: 26491287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
    Feng S; Zou L; Wang H; He R; Liu K; Zhu H
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure.
    Johnson AM; Roach JP; Hu A; Stamatovic SM; Zochowski MR; Keep RF; Andjelkovic AV
    FASEB J; 2018 May; 32(5):2615-2629. PubMed ID: 29295866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice.
    Oppenheim HA; Lucero J; Guyot AC; Herbert LM; McDonald JD; Mabondzo A; Lund AK
    Part Fibre Toxicol; 2013 Dec; 10():62. PubMed ID: 24344990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects.
    Haseloff RF; Dithmer S; Winkler L; Wolburg H; Blasig IE
    Semin Cell Dev Biol; 2015 Feb; 38():16-25. PubMed ID: 25433243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrier function in the peripheral and central nervous system-a review.
    Reinhold AK; Rittner HL
    Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-3-deficient C57BL/6J mice display intact brain barriers.
    Castro Dias M; Coisne C; Lazarevic I; Baden P; Hata M; Iwamoto N; Francisco DMF; Vanlandewijck M; He L; Baier FA; Stroka D; Bruggmann R; Lyck R; Enzmann G; Deutsch U; Betsholtz C; Furuse M; Tsukita S; Engelhardt B
    Sci Rep; 2019 Jan; 9(1):203. PubMed ID: 30659216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.